Rankings
▼
Calendar
BEAM Q2 2019 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6,000
Gross Profit
-$13M
-211233.3% margin
Operating Income
-$18M
-294183.3% margin
Net Income
-$18M
-297683.3% margin
EPS (Diluted)
$-0.51
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$18M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$181M
Total Liabilities
$37M
Stockholders' Equity
$144M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6,000
$0
—
Gross Profit
-$13M
-$7M
-78.9%
Operating Income
-$18M
-$10M
-81.1%
Net Income
-$18M
-$10M
-76.3%
← FY 2019
All Quarters
Q3 2019 →